Skip to main content
All Posts By

Recuro Health

Blog
August 2, 2021

Delta Variant, Stalled Vaccination Rates, New Directives from Federal/State Governments, CDC and Employers Increase Demand for Recuro’s At-Home & In-office COVID Testing Solution

‘Vaccinate or Get Tested’ is the new policy from all corners of government and private industry amid the surge of the Delta variant, recurrence of disease even among those who have been vaccinated and a plateau in vaccination rates. Testing often is rapidly being adopted across the country as a key to stopping the virus spread. But fulfilling these directives requires employers…
Media
July 28, 2021

Spotlight Interview: John Halsey, Chief Growth Officer, Recuro & Michael Brombach, Executive Director, Recuro

Medical Travel & Digital Health News (MTDHN):  First, tell our readers why Recuro’s COVID-19 PCR rapid testing is a vital component of every employer’s back-to-work strategy – what are the key issues that employers should be looking at? The follow up to this discussion is Recuro’s role with the travel industry and why the testing is critical for passengers returning…
Blog
July 26, 2021

Recuro’s At-Home Testing Expert Shares “Best Practices” and Industry Future at American Telemedicine Association’s 2021 Conference

Allison Martin, a founder and executive director of Recuro Health, recently joined a panel at the American Telemedicine Association’s annual conference to talk about emerging tech for lingering gaps in virtual care and exploring remote testing and diagnostics in the home. Recuro’s at-home diagnostic and health screening software platform is designed to personalize the at-home testing experience. Its COVID-19 rapid…
Blog
July 20, 2021

Recuro Acquires Genomics Risk Stratification Tool: Expanding Capabilities for Personalized Care and Streamlining Full Continuum of Care

Genetic testing has been available for several years. Consumer genomics is very popular now with the medically focused use of genetic testing growing rapidly at the same time. In 2020, the genetic marketing trend exceeded $14.8 billion and is expected to have a 11-13% annual growth rate in 2021-2027. The industry’s growth is attributable to the increasing prevalence of chronic…
Press Release
July 15, 2021

Recuro Health Integrated Solutions Platform Supports Employers, Payers, Government Manage Population Health Post COVID: Featured at HHS RADx Summit

DALLAS — (BUSINESS WIRE) — Recuro Health (Recuro), an integrated digital health solution that evolves healthcare from a reactive, disease-focused model to a personalized, proactive system, will be featured at the Association of Chamber of Commerce Executives (ACCE) Innovation Summit July 19-21 sponsored by RADx, an initiative of the U.S. Department of Health and Human Services (HHS). Recuro’s integrated, interoperable population health management platform and…
Blog
June 30, 2021

Recuro Health’s Digital Solutions Promote Integration of Behavioral and Physical Health, More Personalized and Convenient Care

Mental health was taboo. The subject was dodged in social circles, sidestepped in the media and completely avoided in the workplace. But awareness has grown. Increasingly, people recognize that both physical and mental health are critical to a person’s overall well-being. You can’t ignore one and expect high marks on the other. There’s significant upside to reducing the stigma around…
Press Release
June 22, 2021

Recuro Health Further Expands Digital Solution Platform: Acquires My Legacy Decision Support App, Integrates Genetic Profiles to Enhance Disease Management & Care Coordination

DALLAS — (BUSINESS WIRE) — Recuro Health (Recuro), an integrated digital health solution that evolves healthcare from a reactive, disease-focused model to a personalized, proactive system, announces the acquisition of MyLegacy, a risk stratification tool and clinical decision support application which uses proprietary algorithms based on practice guidelines developed by the Cleveland Clinic Genomic Medicine Institute. This acquisition further increases the…
Media
June 15, 2021

Recuro Health Acquires UDoTest (Michael Gorton & Allison Martin discuss the acquisition)

https://youtu.be/7woPjmJgbYQ Michael Gorton, CEO at Recuro Health, and Allison Martin, CEO & Founder at UDoTest discuss Recuro Health’s recent acquisition of UDoTest with Slice of Healthcare host, Jared S. Taylor. “There’s there’s going to be more acquisitions over the next year or so. John Halsey and I have talked to 156 companies. Three are done and we’ve got a few…
Blog
May 27, 2021

Expanded Digital Care Platform Enhances Virtual Primary Care and Behavioral Health Solutions

We are pleased to announce that Recuro Health recently acquired SupDoc, an AI-enabled virtual health solution that offers a holistic and cost-effective model for care delivery. SupDoc will enhance Recuro’s digital health platform, a curated suite of telehealth solutions that enables consumers to engage with physicians, receive personalized care and monitor their own health, no matter their location or circumstance.…
Press Release
May 24, 2021

Recuro Health At-Home COVID-19 Rapid Testing Solution Featured at U.S. Census Bureau & Department of Health & Human Services COVID-19 TOPx Solutions Showcase

DALLAS — (BUSINESS WIRE) — Recuro Health At-Home Testing (otherwise known as UDoTest), an at-home diagnostic and health screening software platform designed to personalize the at-home testing experience, announces that its COVID-19 rapid test solution will be featured at the HHS TOPx Solution Showcase, Thursday, May 25, 2021, 12-3 p.m. ET. The virtual event is co-hosted by the U.S. Census Bureau…